United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 340,100 | 174,560 | 304,442 | 217,868 | 105,916 |
| Depreciation Amortization | 32,200 | 48,361 | 42,813 | 44,368 | 37,333 |
| Income taxes - deferred | N/A | N/A | 136,229 | 81,432 | 41,923 |
| Accounts receivable | -35,700 | -10,027 | -23,991 | -16,158 | -23,452 |
| Accounts payable and accrued liabilities | -6,800 | 7,507 | -22,804 | 20,251 | -2,734 |
| Other Working Capital | -200,500 | -112,323 | -208,192 | -111,254 | -72,411 |
| Other Operating Activity | 226,000 | 317,189 | 95,131 | 13,688 | 124,957 |
| Operating Cash Flow | $355,300 | $425,267 | $323,628 | $250,195 | $211,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 430,900 | -232,298 | -51,458 | -81,808 | -204,497 |
| PPE Investments | -47,400 | -31,910 | -111,905 | -35,978 | -18,640 |
| Purchase Of Investment | -45,000 | -30,766 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | 0 | N/A | -3,547 | 0 |
| Other Investing Activity | 0 | 0 | 0 | -3,547 | 13,901 |
| Investing Cash Flow | $338,500 | $-294,974 | $-163,363 | $-121,333 | $-209,236 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 140,000 | 0 | 0 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 250,000 | 70,000 |
| Debt Repayment | -177,800 | -1,320 | -999 | -284,289 | -31,442 |
| Common Stock Issued | 53,500 | 29,345 | 16,805 | 24,398 | 85,427 |
| Common Stock Repurchased | -483,100 | -42,439 | -188,000 | -212,000 | 0 |
| Other Financing Activity | -109,200 | 9,299 | 3,054 | 3,812 | 22,771 |
| Financing Cash Flow | $-576,600 | $-5,115 | $-169,140 | $-218,079 | $146,756 |
| Exchange Rate Effect | -3,800 | -319 | 229 | -269 | 2,758 |
| Beginning Cash Position | 284,300 | 159,399 | 168,045 | 252,162 | 100,352 |
| End Cash Position | 397,700 | 284,258 | 159,399 | 162,676 | 252,162 |
| Net Cash Flow | $113,400 | $124,859 | $-8,646 | $-89,486 | $151,810 |
| Free Cash Flow | |||||
| Operating Cash Flow | 355,300 | 425,267 | 323,628 | 250,195 | 211,532 |
| Capital Expenditure | -47,400 | -31,910 | -111,905 | -35,978 | -18,640 |
| Free Cash Flow | 307,900 | 393,357 | 211,723 | 214,217 | 192,892 |